Briefly,
the cohort includes individuals who were treated for leukemia,
lymphoma, central nervous system (CNS) malignancy,
kidney cancer, neuroblastoma, malignant bone
tumor, or soft tissue sarcoma at 26 institutions in the
U.S. and Canada.
Briefly,the cohort includes individuals who were treated for leukemia,lymphoma, central nervous system (CNS) malignancy,kidney cancer, neuroblastoma, malignant bonetumor, or soft tissue sarcoma at 26 institutions in theU.S. and Canada.
การแปล กรุณารอสักครู่..
